Patents

US 11896600 B2: Composition and method of using eicosanoyl-5-hydroxytryptamide for treating neurodegenerative disorders

Granted
2024-02-13
Filed
2020-09-20 application 17026263
Type
Utility · 22 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The invention provides a composition comprising one or more hydroxytryptamides and method of its use in the treatment of neurodegenerative disorders. The invention includes embodiments wherein the composition comprises caffeine and chlorogenic acids. The composition finds use in the treatment of Alzheimer's disease and Parkinson's disease, including providing neuroprotection against the advancement of the symptoms of these disorders.

Source: PVGPATDIS, file of 2026-04-10 (ipg240213_r1.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Vidya Herbs, Inc. 24 patentsUS company or organizationFullerton, CAPVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Kodimule Shyam PrasadKanchinakote, IN28PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K31/559PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P25/28PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.